Funding Rounds
Emergence Therapeutics

Emergence Therapeutics Series A round, December 2021

Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $92.30M

Raised Date: 2021-12-13